[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Resmed Inc (RMD)

Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,571,984
  • Shares Outstanding, K 145,678
  • Annual Sales, $ 5,146 M
  • Annual Income, $ 1,401 M
  • EBIT $ 1,941 M
  • EBITDA $ 2,177 M
  • 60-Month Beta 0.84
  • Price/Sales 5.88
  • Price/Cash Flow 18.22
  • Price/Book 4.58

Options Overview Details

View History
  • Implied Volatility 29.71% (+1.80%)
  • Historical Volatility 25.51%
  • IV Percentile 56%
  • IV Rank 29.38%
  • IV High 52.18% on 10/30/25
  • IV Low 20.36% on 08/13/25
  • Expected Move (DTE 28) 10.65 (5.08%)
  • Put/Call Vol Ratio 0.78
  • Today's Volume 245
  • Volume Avg (30-Day) 1,018
  • Put/Call OI Ratio 1.76
  • Today's Open Interest 11,163
  • Open Int (30-Day) 15,589
  • Expected Range 199.21 to 220.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.90
  • Number of Estimates 5
  • High Estimate $2.92
  • Low Estimate $2.88
  • Prior Year $2.55
  • Growth Rate Est. (year over year) +13.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
198.61 +5.66%
on 05/11/26
227.31 -7.68%
on 04/21/26
-16.28 (-7.20%)
since 04/20/26
3-Month
198.61 +5.66%
on 05/11/26
261.91 -19.87%
on 02/23/26
-49.26 (-19.01%)
since 02/20/26
52-Week
198.61 +5.66%
on 05/11/26
293.81 -28.57%
on 08/22/25
-38.28 (-15.43%)
since 05/20/25

Most Recent Stories

More News
3 Large-Cap Stocks to Consider Right Now

3 Large-Cap Stocks to Consider Right Now

ALL : 220.00 (-0.89%)
AMP : 457.27 (-1.40%)
RMD : 209.86 (+1.00%)
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference

SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the...

RMD.AX : 29.600 (+1.16%)
RMD : 209.86 (+1.00%)
Resmed and ÅŒURA Partner to Expand Access to Sleep Health Education and Care

SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, and ŌURA, maker of the world’s...

RMD.AX : 29.600 (+1.16%)
RMD : 209.86 (+1.00%)
ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions

ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions

RMD : 209.86 (+1.00%)
S&P 500 and Nasdaq 100 Post Record Highs on Solid Earnings

The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +0.29%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.94%. June E-mini...

MSTR : 165.00 (-0.49%)
ALK : 39.31 (-1.36%)
AAPL : 301.63 (-0.21%)
INTU : 323.04 (-15.86%)
SNDK : 1,390.40 (-0.16%)
DDOG : 209.87 (-1.12%)
GLXY : 28.06 (+1.04%)
VEEV : 161.41 (-2.15%)
$IUXX : 29,297.70 (+1.66%)
AMGN : 330.98 (-0.18%)
COIN : 191.00 (-0.15%)
CLX : 94.00 (-0.28%)
Stocks Climb on Strong Earnings and Crude Oil Weakness

The S&P 500 Index ($SPX ) (SPY ) today is up +0.62%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.10%. June E-mini S&P futures (ESM26...

MSTR : 165.00 (-0.49%)
AAPL : 301.63 (-0.21%)
INTU : 323.04 (-15.86%)
ADI : 396.40 (-0.41%)
DDOG : 209.87 (-1.12%)
GLXY : 28.06 (+1.04%)
VEEV : 161.41 (-2.15%)
$IUXX : 29,297.70 (+1.66%)
AMGN : 330.98 (-0.18%)
COIN : 191.00 (-0.15%)
CLX : 94.00 (-0.28%)
ZNM26 : 109-030 (-0.29%)
RMD Q1 Deep Dive: Mask Portfolio Drives Growth Amid Market Uncertainty and New CFO Appointment

RMD Q1 Deep Dive: Mask Portfolio Drives Growth Amid Market Uncertainty and New CFO Appointment

RMD : 209.86 (+1.00%)
2 Cash-Heavy Stocks with Exciting Potential and 1 We Turn Down

2 Cash-Heavy Stocks with Exciting Potential and 1 We Turn Down

TPL : 402.50 (-0.01%)
HDSN : 4.96 (+1.43%)
RMD : 209.86 (+1.00%)
ResMed’s (NYSE:RMD) Q1 CY2026 Sales Beat Estimates

ResMed’s (NYSE:RMD) Q1 CY2026 Sales Beat Estimates

RMD : 209.86 (+1.00%)
ResMed: Fiscal Q3 Earnings Snapshot

ResMed: Fiscal Q3 Earnings Snapshot

RMD : 209.86 (+1.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory...

See More

Key Turning Points

3rd Resistance Point 216.43
2nd Resistance Point 214.09
1st Resistance Point 211.97
Last Price 209.86
1st Support Level 207.51
2nd Support Level 205.17
3rd Support Level 203.05

See More

52-Week High 293.81
Fibonacci 61.8% 257.44
Fibonacci 50% 246.21
Fibonacci 38.2% 234.98
Last Price 209.86
52-Week Low 198.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.